Apogee Therapeutics APGE

Monthly Leaders · June 2026 · Updated September 4, 2026

Health CareNews Spike

Setup Snapshot

The Setup in One Card

How APGE scored, how it moved against the market, and the catalyst behind the move. A high score means the stock deserves research time, not that it is a buy.

Friday Five Score

June 2026 Return

APGE+61.59%

June 2026

+61.59% · Rank 1

Sector Trend

Improvingup 1.0 percent

Actionability

News Spike

Catalyst

Acquisition

Takeout agreement at $135 per share in cash

Top five stocks covered by The Friday Five in June, ranked by full month price return (May 29 close to June 30 close).

Continue the Research

Put APGE Back in Context

The stock page is one piece of the weekly research. Continue with the original issue, the full public ranking, or the method behind the analysis.

Search Every Published Pick

Filter the full record by sector, issue or whether the pick beat the index.

How to Read the Research

Open the public plain-English explanation connected to this research.

← Back to the full scoreboard

This page is for educational and informational purposes only. It is not financial advice, investment advice, or a recommendation to buy or sell any security.